Group A Streptococcus (GAS) has long been recognized as a human pathogen causing an exceptionally broad range of infections. However, despite intense research, the molecular mechanisms of GAS disease remain unclear. Recently, many important discoveries have been made that shed light on GAS pathogenesis and open exciting new avenues for future research. Advances in genome sequencing, microarray technology and proteomic analysis in combination with the development of more suitable animal models have dramatically increased the amount of data regarding the mechanisms of GAS pathogenesis. The information gained from these studies will translate into the identification of improved diagnostics and new targets for novel therapeutic drugs and vaccines. 
requires the bacterium to break out of the local site of infection and survive in the blood.
To accomplish each of these transitions, GAS has evolved sophisticated strategies and complex regulatory mechanisms that allow it to thwart host defenses and successfully colonize, thrive and/or persist in the host. Many proven and putative virulence factors made by GAS contribute to host-pathogen interactions (Fig. 1) . In this review, we discuss recent advances in the understanding of GAS pathogenesis and focus on the role of a variety of streptococcal virulence factors in the establishment and dissemination of disease. While the mechanistic basis of the regulation of many of these virulence factors is extremely important, a complete treatment of this topic is beyond the scope of this review.
Survival of GAS in human saliva
The oropharynx is the primary site of GAS entry into the human host. In this environment, GAS encounters saliva, which contains components of the innate and the acquired immune system including antimicrobial peptides that limit the growth of pathogenic bacteria. It has been known since the 1940s that saliva containing high levels of GAS plays a role in the person-to-person spread of this pathogen [1] [2] [3] . Recent in vitro analysis of the interaction between human saliva and GAS reveals that the microorganism has evolved a mechanism that allows it to persist in saliva at relatively high viable cell numbers for prolonged periods of time 4 . This phenomenon is specific for saliva, as GAS grown in either limited or defined liquid media did not remain viable for long time
periods. It was also demonstrated that serotype M1 strains of GAS reach higher concentrations in human saliva than strains of other serotypes. Considering that M1
strains are a leading cause of streptococcal pharyngitis 5 , it may be that the relatively high density achieved in saliva by certain GAS serotypes enhances their likelihood of being transmitted to a new host.
Shelburne et al. 6 discovered that a two-component regulatory system of previously unknown function mediates the persistence of GAS in human saliva. This two-component system, designated sptR/S for saliva persistence, directly or indirectly controls expression of about 8% of the GAS genome in exponential growth phase and a striking 20% of the genome during stationary growth phase 6 . Of the genes controlled by sptR/S, genes involved in carbohydrate metabolism are most abundantly represented. One of the genes discovered to aid GAS survival in saliva is malE, which encodes a highly conserved maltodextrin-binding protein present in a broad range of GAS strains 6,7 .
human saliva may represent an important reservoir for GAS, which is critical for both persistence and transmission of the pathogen.
Pharyngeal disease
Although GAS is able to cause serious invasive disease, pharyngitis is by far the most common infection. For example, ~15 million cases of streptococcal pharyngitis occur annually in the US alone, resulting in an estimated 2 billion dollars of direct health care costs 8 . However, despite decades of research, our knowledge of the precise molecular events mediating GAS pharyngitis remains rudimentary. Recently, three strategies have been used to expand our understanding regarding the pathogenesis of this infection. One line of productive research that has yielded new information about GAS-host interactions has used mouse nasal-associated lymphoid tissue (NALT) 9-11 . Use of NALT and a bioluminescent-tagged GAS strain has suggested that M cells in NALT transport GAS across the epithelial cell layer, perhaps facilitating invasion of deeper tissues 9 . NALT also has been used to study immune responses to GAS 10 .
A second line of investigation has used gene transcript analysis of GAS in primary throat swabs obtained from patients with pharyngitis. Virtaneva et al. 12 used real time reverse-transcription PCR (RT-PCR) to study transcripts of 17 GAS genes in throat swab specimens obtained from 18 pediatric patients diagnosed with acute pharyngitis.
This method allowed the analysis of GAS gene expression in vivo, thereby opening a new avenue of investigation. Genes belonging to two component regulatory systems, regulatory genes, and genes encoding proven and putative virulence factors were studied. A third line of research has used a cynomolgus macaque model of pharyngitis 12, [17] [18] [19] . Due to high human host specificity of GAS, rodent models are inadequate in their representation of pharyngitis pathogenesis because they neither precisely mimic human GAS disease nor the host response against GAS infection. 
Vascular leakage and survival of GAS in plasma and blood
When GAS causes superficial infections, it is exposed to human plasma at sites of inflammation as a consequence of vascular leakage, which is mediated in part by the interaction of M protein and fibrinogen with the β 2 -integrin adhesion molecule on the surface of neutrophils (PMNs). This complex results in a massive inflammatory response which involves the release of heparin binding protein (HBP) and induces vascular leakage 34 . As augmented vascular permeability is one of the underlying pathophysiological mechanism in shock, the crosslinking of the M protein and fibrinogen with β 2 -integrin may play an important role in the establishment of STSS. Plasma is a rich medium that supports bacterial growth, however it also contains many immune system components which GAS must elude to survive, including opsonizing antibodies and complement. Many plasma protein-GAS protein interactions interfere with the proper function of host defenses 5, 35 . Moreover, GAS expresses surface proteins that have a high affinity for several human plasma proteins such as albumin, fibrinogen, α 2 -macroglobulin, IgG, and plasminogen 5, [35] [36] [37] [38] , which suggests that the pathogen has evolved mechanisms to capture and use host proteins for enhanced survival in vivo.
To examine the effect of plasma on GAS protein expression, Johansson et al. 39 compared the proteomes of serotype M1 strain AP1 cultured in laboratory medium or in human plasma. Expression of 39 protein spots representing 24 unique GAS proteins, was significantly increased in cells cultured in human plasma. Interestingly, multiple spots for secreted extracellular proteins C5a peptidase and M1 were present in the proteome of plasma-grown bacteria, but were absent in the proteome of strain AP1 grown in laboratory medium. Concurrent with these data, a truncated variant of M1 protein lacking the N-terminal 13 amino acids of the mature, full-length protein was identified, a finding indicative of post-translational modification of this key virulence factor in response to plasma exposure 39 .
We have only limited knowledge of changes in protein expression in GAS cultured in blood compared to laboratory media. However, Graham et al. 40 have demonstrated that GAS undergoes a rapid and extensive remodeling of its transcriptome when grown in human blood ex vivo. Within 30 min after initial contact of GAS with whole blood, transcripts of 716 genes (representing 37% of the GAS genome) were upregulated whereas 425 transcripts (22% of the genome) were down-regulated. Transcripts of genes belonging to functional categories expected to be important for growth adaptation in blood including de novo synthesis of macromolecular precursors, carbohydrate metabolism, membrane transport, and transcriptional regulation were increased. Expression of several virulence genes was up-regulated, including the multigene activator mga and its regulated transcripts emm1, sic, streptolysin, and has (capsular polysaccharide) 40 . Evidence for the up-regulation of capsule expression of GAS in blood in vivo was provided by Gryllos et al. 41 who showed that there is a temporal relationship between capsule gene expression and proliferation of GAS in the blood of infected mice.
Transition from local to systemic infection
Each year GAS causes an estimated 700 million cases of mild non-invasive infections such as pharyngitis and impetigo worldwide. Approximately 700,000 of these develop into severe invasive disease 42 . The exact mechanism mediating the switch from a localized to a systemic infection remains to be elucidated. One factor that is thought to contribute to this process is the binding of GAS to human plasminogen and its subsequent activation to the broad-spectrum protease plasmin [43] [44] [45] [46] [47] . It was hypothesized that plasminogen is supplied by vascular leakage at the site of infection. There is evidence that GAS assembles a trimolecular complex consisting of fibrinogen, plasminogen, and streptokinase, which is associated with a propensity for invasive disease 48, 49 . Recent studies using a humanized transgenic mouse model confirmed the important role for human plasminogen in the dissemination of GAS in vivo 37, 45 and lead to the proposal that GAS may subvert human plasminogen for use as a virulence factor 36, 45 . Interestingly, GAS also produces the cysteine protease SpeB, which has been shown to directly degrade the trimolecular complex 48 . Differential regulation of speB expression seems to play a role in the transitioning from localized to invasive disease. The speB gene is found in over 99% of GAS isolates and is highly conserved, and production of SpeB has been shown to be important in the establishment of localized GAS infections 37, 50, 51 . Kansal et al. 52 observed that SpeB levels vary greatly in both clonally related and unrelated strains and that expression of SpeB and human invasive disease severity are inversely related in M1T1 GAS isolates. In addition, passage of speB expressing GAS strains in mice resulted in a downregulation of speB concomitantly with the upregulation of M protein expression 52
. Moreover, Cole et al. 37 discovered that there is a subpopulation of GAS in localized infections that can lose SpeB activity. This ultimately results in an accumulation of plasmin activity on the GAS cell surface and equips this particular subpopulation with enhanced invasive potential. Ultimately, this may result in the transition of GAS from the local site of infection to the blood and promotes dissemination to other parts of the host.
To gain additional information about the GAS genes expressed during skin and soft tissue infection, Graham et al. 53 analyzed the transcriptome of GAS in mouse soft tissue infection. The transcriptome of a serotype M1 strain was studied, and array datasets were verified by quantitative real-time RT-PCR and in situ immunohistochemistry. The results demonstrated that coordinated expression of GAS virulence factors is directed toward overcoming innate host defenses, resulting in severe cellular damage. In addition, several classes of genes were found to be highly expressed in vivo, including oxidative stress genes, virulence genes, genes related to complex carbohydrate utilization, and several two-component transcriptional regulators. This study was the first global analysis of the GAS transcriptome in invasive infection and produced many new avenues for basic and translational research.
Severe invasive disease
Severe invasive GAS infections have re-emerged on a global level since the mid1980s. These infections can progress rapidly and are associated with exceedingly high rates of morbidity and mortality 54 . Many strains causing necrotizing fasciitis, an especially severe and destructive infection, are serotype M1 and M3 strains [54] [55] [56] , which suggests that particular GAS strains have an increased propensity to cause invasive disease.
Sumby et al. 57 described two distinct transcriptome profiles of GAS that were were more resistant than PTP organisms to phagocytosis and killing by human neutrophils. To discover the genetic changes underlying the two distinct transcriptome profiles, complete genome re-sequencing of a mouse-derived ITP strain was conducted 57 .
The genome of the ITP derivative organism differed from the PTP precursor strain by only a 7-bp frameshift mutation located in the covS gene, which encodes the sensor kinase of the CovR/S two-component regulatory system. CovR/S directly or indirectly controls approximately 15% of the GAS transcriptome 58 .
The frameshift mutation truncates CovS, resulting in the de-repression of many genes encoding proven virulence factors, including speA (streptococcal pyrogenic exotoxin A), sagA (streptolysin S), mac, ska (streptokinase), and spd3. Consistent with these findings, Engleberg et al. 59 reported There is also evidence that mtsR, a gene encoding a metal transport regulator, may play a role in deep-muscle infections [63] [64] [65] . Using comparative genome re-sequencing, Beres et al. 65 discovered that strains containing a naturally occurring mutation in mtsR, which yields a severely truncated MtsR protein, are significantly underrepresented among GAS isolates recovered from necrotizing fasciitis cases. These results suggest that MtsR is necessary for the full virulence potential of GAS in invasive disease. Expression microarray analysis found that this truncation mutation is linked to significantly altered transcript levels of multiple genes and operons involved in metal homeostasis and response to oxidative stress 65 , which perhaps renders the pathogen more vulnerable to the host immune response.
The molecular processes contributing to tissue destruction in GAS necrotizing fasciitis and myonecrosis remain poorly understood. Recent studies have provided important evidence that streptolysin O-induced platelet/neutrophil complexes play a role in development of ischemic necrosis of tissue 66 . In related work, Bryant et al. 67 showed
that an early step in the pathogenesis of GAS myonecrosis may involve binding of the pathogen to vimentin, a molecule that is up-regulated after skeletal-muscle injury.
Asymptomatic carriage
GAS is exclusively a human pathogen and therefore must survive in a human reservoir.
Many individuals carry GAS asymptomatically in the upper respiratory tract and other anatomic sites. Over the years there have been several hypotheses to explain this phenomenon. In principle, asymptomatic carriage of GAS could arise as a consequence of mutations in the pathogen that down-regulate virulence, a productive immune response by the host that constrains pathogen proliferation, internalization into host cells, or some combination thereof. Relatively little work has been done to study the genetic relationships between strains causing disease episodes and those of the same M protein serotype that are recovered from asymptomatic carriers. However, this issue can now be studied at the genome-wide level. To address this issue, Beres et al. 68 used comparative genome re-sequencing to show that several serotype M3 strains from asymptomatic throat carriers contained deletion mutations in the pleiotrophic virulence regulatory gene mga and the emm gene. The occurrence of these mutations in the carrier isolates but not in disease-causing organisms implicates them in down-regulating virulence. Consistent with this idea, carrier strains were significantly less virulent, as assessed by intraperitoneal injection into mice 68 . Thus, these data support the hypothesis that asymptomatic carriage may arise as a consequence of mutations that down-regulate virulence.
While GAS has long been regarded as an extracellular pathogen, there has been evidence that it can invade non-phagocytic cells [69] [70] [71] [72] . This observation has led to conjecture that internalization of GAS by host cells participates in the carrier state 5, 70, 73 .
GAS internalization may allow the pathogen to evade certain host defenses and protect it from killing by antibiotics such as penicillin, as this antibiotic does not enter epithelial cells 70 . Consistent with this idea, Sela et al. 70 observed that strains escaping antibiotic killing had significantly higher internalization efficiencies than strains that were successfully eliminated by antibiotic therapy. Other investigators have reported that genes encoding proteins that are linked to internalization, such as those encoding fibronectin-binding proteins F2, SfbI, and PfbpI, are significantly more prevalent among persisting GAS strains recovered from asymptomatic carriers 5, 73 . However, Brandt et al. 74 found no evidence for an increased prevalence of the prtF1 gene among GAS isolates recovered from pharyngitis patients who had antibiotic treatment failure. Hence, the literature bearing on this issue remains unclear and additional work is required to elucidate the role of host-cell internalization in asymptomatic carriage and other aspects GAS biology and pathogenesis.
Asymptomatic carriage of GAS also may have a role in some invasive infections.
Medina and colleagues observed that the intracellular survival of GAS in neutrophils may result in increased bacterial virulence 75 . Using a mouse model, it was shown that ingested GAS is transported by neutrophils to distant parts of the body 75 . This is a notable finding as it may explain the cases of necrotizing fasciitis occurring in the absence of an entry wound or trauma adjacent to the site of GAS infection.
Concluding remarks
This review has highlighted some recent advances in our understanding of GAS pathogenesis and its interaction with the human host at various sites of infection. Many of the important findings have been made possible by contemporary genome sequencing, microarray technology and proteome analysis. Combined use of these technologies permits a global interrogation of molecular events that occur during host-pathogen interactions. Their use has revealed that GAS responds rapidly and in a regulated manner to the distinct environments encountered in the host during the establishment and dissemination of disease (Fig. 2) . In the future, these approaches will be useful in identifying molecular markers specific for each phase of the disease process. This is especially important for severe invasive GAS diseases, which progress rapidly and are frequently diagnosed too late due to the current lack of appropriate diagnostics. invasive soft-tissue infection 53 , and during growth in saliva 6 and blood 40 . 
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